Kenji Fujita – Biography

Last update: January 9, 2026

Executive profile

Kenji was Vice President at Alnylam Pharmaceuticals, and Executive Director, Clinical ResearcH at Alexion Pharmaceuticals.

Kenji Fujita is currently

Chief Financial Officer at Atsena Therapeutics - View - Atsena Therapeutics org chart



Create your alert
to follow the career of Kenji Fujita.

Education

Kenji Fujita has a Bachelor in Biochemistry from Harvard University in 1994 and a Doctor of Medicine from Harvard Medical School in 2000.

They have also studied at Harvard University :

Find more alumni from Harvard University


They have also studied at Harvard Medical School :

Find more alumni from Harvard Medical School

More about Kenji Fujita

The colleagues of Kenji Fujita

Company Colleagues
Homonyms
  • Kenji Fujita - General Manager, Financial Markets Department - Bank of Japan
Industry Colleagues
  • In the Biotechnology industry, Kenji Fujita has 35,756 colleagues in 2,407 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of Kenji Fujita.

Get in Touch

Here are a few tips for establishing great contacts.

Through the switchboard, call Atsena Therapeutics at +1 302... and ask for Kenji Fujita.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.